Hana Pharm Co Ltd (293480) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.005x

Based on the latest financial reports, Hana Pharm Co Ltd (293480) has a cash flow conversion efficiency ratio of -0.005x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-1.41 Billion ≈ $-958.88K USD) by net assets (₩306.17 Billion ≈ $207.49 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Hana Pharm Co Ltd (293480) balance sheet quality index to measure how much of total assets are equity-financed.

Hana Pharm Co Ltd - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Hana Pharm Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 293480 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.

Hana Pharm Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Hana Pharm Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
SD Standard Drilling PLC OL:SDSD	0.153x
My Humble House Hospitality Management Consulting Co Ltd TW:2739	0.458x
Loxley Public Company Limited BK:LOXLEY	-0.044x
Tera Autotech TWO:6234	0.013x
Tait Marketing & Distribution Co Ltd TWO:5902	0.062x
Prime Securities Limited NSE:PRIMESECU	-0.056x
Leo Systems TWO:5410	0.402x
Alpha Astika Akinita S.A AT:ASTAK	-0.330x

Annual Cash Flow Conversion Efficiency for Hana Pharm Co Ltd (2016–2024)

The table below shows the annual cash flow conversion efficiency of Hana Pharm Co Ltd from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Hana Pharm Co Ltd.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩309.18 Billion ≈ $209.52 Million	₩25.30 Billion ≈ $17.14 Million	0.082x	+23.60%
2023-12-31	₩277.98 Billion ≈ $188.39 Million	₩18.40 Billion ≈ $12.47 Million	0.066x	-42.46%
2022-12-31	₩268.40 Billion ≈ $181.89 Million	₩30.88 Billion ≈ $20.93 Million	0.115x	+12.98%
2021-12-31	₩251.90 Billion ≈ $170.71 Million	₩25.66 Billion ≈ $17.39 Million	0.102x	+51.91%
2020-12-31	₩232.38 Billion ≈ $157.48 Million	₩15.58 Billion ≈ $10.56 Million	0.067x	-53.43%
2019-12-31	₩220.33 Billion ≈ $149.32 Million	₩31.72 Billion ≈ $21.49 Million	0.144x	+7.17%
2018-12-31	₩205.39 Billion ≈ $139.19 Million	₩27.59 Billion ≈ $18.70 Million	0.134x	-56.98%
2017-12-31	₩81.30 Billion ≈ $55.09 Million	₩25.38 Billion ≈ $17.20 Million	0.312x	+38.97%
2016-12-31	₩55.48 Billion ≈ $37.60 Million	₩12.46 Billion ≈ $8.45 Million	0.225x	--

About Hana Pharm Co Ltd

KO:293480 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$101.53 Million

₩149.81 Billion KRW

Market Cap Rank

#19063 Global

#894 in Korea

Share Price

₩8660.00

Change (1 day)

+1.88%

52-Week Range

₩8250.00 - ₩12290.00

All Time High

₩26028.86